Sally C. Pipes
Commentary
The GLP-1 Shortage Is Over. Mass-Market Compounding Should Be, Too
The U.S. Food and Drug Administration’s effort to rein in mass-market copies of blockbuster GLP-1 drugs just survived a major legal challenge. Last month, the U.S. Court of Appeals for the Fifth Circuit upheld the agency’s determination that the shortage of semaglutide—the active ingredient in Ozempic and Wegovy—is over. In ...
Commentary
The first mRNA flu vaccine may be just the beginning
Flu season is coming. And for the first time, Americans will have an mRNA vaccine to help fight it. Last month, the Food and Drug Administration approved Moderna’s mFLUSIVA for adults 50 and older. In a large Phase 3 trial, the vaccine was almost 27% more effective than a standard ...
Commentary
Mark Cuban: Insurance Can Make Prescription Drugs Cost More
Billionaire entrepreneur Mark Cuban has picked another fight with pharmacy benefit managers, the powerful middlemen insurers hire to manage prescription drug benefits. His complaint is straightforward. The PBM-controlled system makes prescription drugs more expensive than they need to be, even for people with insurance. At a Texas State House hearing ...
Commentary
Millions of women missing breast cancer screenings due to red tape
More than 8 million American women between 45 and 64 are overdue for breast-cancer screening. That’s a staggering number for a disease expected to kill more than 40,000 women this year. The consequences of finding breast cancer late can be devastating. Five years after diagnosis, women whose cancer remains confined ...
Commentary
Use Trade Policy to Push Wealthy Nations to Pay More for Meds
President Trump just announced another round of agreements with pharmaceutical companies under his “most-favored-nation” drug pricing initiative. The nine new deals bring the total number of participating manufacturers to 26, covering nearly 90% of the branded-drug market. The campaign targets a real problem. Many wealthy countries use price controls to ...
Commentary
A new name for a better way to buy health insurance
Federal officials just gave one of the most promising innovations in health insurance a badly needed name change. The Centers for Medicare and Medicaid Services has rebranded Individual Coverage Health Reimbursement Arrangements — otherwise known as ICHRAs — as “CHOICE Arrangements,” short for Custom Health Option and Individual Care Expense. ...
Commentary
GOP Shouldn’t Run Away from Healthcare Reform
The Midterms Loom, Republicans Would Be Wise to Run on Healthcare Reform Ever since the congressional GOP failed to repeal Obamacare and then lost the 2018 midterms, Republicans have shied away from running on market-based healthcare reform. But that’s the wrong strategy, according to President Trump’s chief pollster Tony Fabrizio ...
Commentary
Association Health Plans Could Give Small Businesses A Break On Health Costs
Small businesses have struggled with the rising cost of health insurance for years. The Trump administration may soon give them a meaningful way to fight back. The Labor Department has submitted a proposed rule to the White House that would establish new pathways for groups of employers to band together ...
Commentary
El-Sayed Promises Medicare for All, His Wife Opted Out
Abdul El-Sayed is riding high after his victory in Michigan’s Democratic Senate primary earlier this month. If victorious on Nov. 3, the Medicare for All champion could soon take his far-left health agenda to Washington. Before he does, he’ll need to reckon with an awkward contradiction in his pitch for ...
Commentary
Socialism polls better than it performs
Nearly 6 in 10 Democrats view socialism positively while less than a third say the same of capitalism, according to a new CBS News/YouGov poll. That’s an ominous sign for this fall’s midterm elections, as socialist ideas increasingly vie for mainstream prominence. Socialist health policies may promise universal access, but ...
The GLP-1 Shortage Is Over. Mass-Market Compounding Should Be, Too
The U.S. Food and Drug Administration’s effort to rein in mass-market copies of blockbuster GLP-1 drugs just survived a major legal challenge. Last month, the U.S. Court of Appeals for the Fifth Circuit upheld the agency’s determination that the shortage of semaglutide—the active ingredient in Ozempic and Wegovy—is over. In ...
The first mRNA flu vaccine may be just the beginning
Flu season is coming. And for the first time, Americans will have an mRNA vaccine to help fight it. Last month, the Food and Drug Administration approved Moderna’s mFLUSIVA for adults 50 and older. In a large Phase 3 trial, the vaccine was almost 27% more effective than a standard ...
Mark Cuban: Insurance Can Make Prescription Drugs Cost More
Billionaire entrepreneur Mark Cuban has picked another fight with pharmacy benefit managers, the powerful middlemen insurers hire to manage prescription drug benefits. His complaint is straightforward. The PBM-controlled system makes prescription drugs more expensive than they need to be, even for people with insurance. At a Texas State House hearing ...
Millions of women missing breast cancer screenings due to red tape
More than 8 million American women between 45 and 64 are overdue for breast-cancer screening. That’s a staggering number for a disease expected to kill more than 40,000 women this year. The consequences of finding breast cancer late can be devastating. Five years after diagnosis, women whose cancer remains confined ...
Use Trade Policy to Push Wealthy Nations to Pay More for Meds
President Trump just announced another round of agreements with pharmaceutical companies under his “most-favored-nation” drug pricing initiative. The nine new deals bring the total number of participating manufacturers to 26, covering nearly 90% of the branded-drug market. The campaign targets a real problem. Many wealthy countries use price controls to ...
A new name for a better way to buy health insurance
Federal officials just gave one of the most promising innovations in health insurance a badly needed name change. The Centers for Medicare and Medicaid Services has rebranded Individual Coverage Health Reimbursement Arrangements — otherwise known as ICHRAs — as “CHOICE Arrangements,” short for Custom Health Option and Individual Care Expense. ...
GOP Shouldn’t Run Away from Healthcare Reform
The Midterms Loom, Republicans Would Be Wise to Run on Healthcare Reform Ever since the congressional GOP failed to repeal Obamacare and then lost the 2018 midterms, Republicans have shied away from running on market-based healthcare reform. But that’s the wrong strategy, according to President Trump’s chief pollster Tony Fabrizio ...
Association Health Plans Could Give Small Businesses A Break On Health Costs
Small businesses have struggled with the rising cost of health insurance for years. The Trump administration may soon give them a meaningful way to fight back. The Labor Department has submitted a proposed rule to the White House that would establish new pathways for groups of employers to band together ...
El-Sayed Promises Medicare for All, His Wife Opted Out
Abdul El-Sayed is riding high after his victory in Michigan’s Democratic Senate primary earlier this month. If victorious on Nov. 3, the Medicare for All champion could soon take his far-left health agenda to Washington. Before he does, he’ll need to reckon with an awkward contradiction in his pitch for ...
Socialism polls better than it performs
Nearly 6 in 10 Democrats view socialism positively while less than a third say the same of capitalism, according to a new CBS News/YouGov poll. That’s an ominous sign for this fall’s midterm elections, as socialist ideas increasingly vie for mainstream prominence. Socialist health policies may promise universal access, but ...